Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.
Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R.
Kudo N, et al. Among authors: ishima t.
Neuropsychopharmacol Rep. 2020 Jun;40(2):150-156. doi: 10.1002/npr2.12098. Epub 2020 Feb 5.
Neuropsychopharmacol Rep. 2020.
PMID: 32022478
Free PMC article.